162 related articles for article (PubMed ID: 7487974)
1. Ribozymes cleave the AML1/MTG8 fusion transcript and inhibit proliferation of leukemic cells with t(8;21).
Matsushita H; Kobayashi H; Mori S; Kizaki M; Ikeda Y
Biochem Biophys Res Commun; 1995 Oct; 215(2):431-7. PubMed ID: 7487974
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in myeloid leukaemic cells by ribozymes targeted against AML1/MTG8.
Matsushita H; Kizaki M; Kobayashi H; Muto A; Ikeda Y
Br J Cancer; 1999 Mar; 79(9-10):1325-31. PubMed ID: 10188872
[TBL] [Abstract][Full Text] [Related]
3. In vitro catalytic activities of DNA/RNA chimeric hammerhead ribozymes against AML1-MTG8 mRNA, a fused gene transcript in acute myeloid leukemia with t(8;21).
Kozu T; Sueoka E; Okabe S; Sueoka N; Komori A; Fujiki H
Biochimie; 1996; 78(11-12):1067-73. PubMed ID: 9150886
[TBL] [Abstract][Full Text] [Related]
4. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
Kasashima K; Sakota E; Kozu T
Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
[TBL] [Abstract][Full Text] [Related]
5. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
6. Detection and subcellular localization of an AML1 chimeric protein in the t(8;21) positive acute myeloid leukemia.
Sacchi N; Schiaffonati L; Magnani I; Pappalardo C; Hughes AJ; Darfler M; Hoogeveen AT
Oncogene; 1996 Jan; 12(2):437-44. PubMed ID: 8570222
[TBL] [Abstract][Full Text] [Related]
7. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor.
Erickson PF; Robinson M; Owens G; Drabkin HA
Cancer Res; 1994 Apr; 54(7):1782-6. PubMed ID: 8137293
[TBL] [Abstract][Full Text] [Related]
8. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
Meyers S; Lenny N; Sun W; Hiebert SW
Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
[TBL] [Abstract][Full Text] [Related]
9. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).
Kozu T; Fukuyama T; Yamami T; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2005 May; 43(1):45-53. PubMed ID: 15723339
[TBL] [Abstract][Full Text] [Related]
10. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).
Zhang Y; Emmanuel N; Kamboj G; Chen J; Shurafa M; Van Dyke DL; Wiktor A; Rowley JD
Genes Chromosomes Cancer; 2004 Aug; 40(4):365-70. PubMed ID: 15188461
[TBL] [Abstract][Full Text] [Related]
11. Designing of chimeric DNA/RNA hammerhead ribozymes to be targeted against AML1/MTG8 mRNA.
Kozu T; Sueoka E; Okabe S; Sueoka N; Komori A; Fujiki H
J Cancer Res Clin Oncol; 1996; 122(4):254-6. PubMed ID: 8601580
[TBL] [Abstract][Full Text] [Related]
12. Expression of AML1 and ETO Transcripts in hematopoietic cells.
Era T; Asou N; Yamaguchi K; Yamasaki H; Kamada N; Nishikawa S; Takatsuki K
Leukemia; 1995 Oct; 9 Suppl 1():S26-8. PubMed ID: 7475308
[TBL] [Abstract][Full Text] [Related]
13. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.
Kozu T; Miyoshi H; Shimizu K; Maseki N; Kaneko Y; Asou H; Kamada N; Ohki M
Blood; 1993 Aug; 82(4):1270-6. PubMed ID: 8353289
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of AML1/MTG8 by asymmetric hammerhead ribozymes.
Szyrach M; Münchberg FE; Riehle H; Nordheim A; Krauter J; Nagel S; Heil G; Heidenreich O
Eur J Biochem; 2001 Jun; 268(12):3550-7. PubMed ID: 11422386
[TBL] [Abstract][Full Text] [Related]
15. [Rearrangements and fusion gene of AML1 and MTG8 in acute myeloid leukemia M2b].
Wang J; Xiao Z; Hao Y
Zhonghua Yi Xue Za Zhi; 1995 Jul; 75(7):399-402, 445. PubMed ID: 7553157
[TBL] [Abstract][Full Text] [Related]
16. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.
Yergeau DA; Hetherington CJ; Wang Q; Zhang P; Sharpe AH; Binder M; Marín-Padilla M; Tenen DG; Speck NA; Zhang DE
Nat Genet; 1997 Mar; 15(3):303-6. PubMed ID: 9054947
[TBL] [Abstract][Full Text] [Related]
17. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.
de Greef GE; Hagemeijer A; Morgan R; Wijsman J; Hoefsloot LH; Sandberg AA; Sacchi N
Leukemia; 1995 Feb; 9(2):282-7. PubMed ID: 7869765
[TBL] [Abstract][Full Text] [Related]
18. [Acute myelogenous leukemia with ins(21;8) expressing AML-1-MTG8 fusion transcript].
Kazama H; Aoyama M; Sameshima Y; Teramura M; Masuda M; Motoji T; Okada M; Mizoguchi H
Rinsho Ketsueki; 1996 Nov; 37(11):1297-302. PubMed ID: 8960665
[TBL] [Abstract][Full Text] [Related]
19. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
[TBL] [Abstract][Full Text] [Related]
20. Significance of MTG8 in leukemogenesis.
Kozu T; Komori A; Sueoka E; Fujiki H; Kaneko Y; Matsui T; Uehara T; Seino Y; Ishii M
Leukemia; 1997 Apr; 11 Suppl 3():297-8. PubMed ID: 9209371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
